$AFMD News Article - Affimed Announces 100% Object
Post# of 44
(Total Views: 181)
Posted On: 11/22/2021 1:50:51 PM
$AFMD News Article - Affimed Announces 100% Objective Response Rate at Highest Dose in Phase 1-2 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13 for CD30-positive Lymphomas https://marketwirenews.com/news-releases/affi...61351.html
(0)
(0)Affimed N.V. (AFMD) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼